Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0379 per EA under NDC 68382025110. Its NADAC has been published 392 times since Dec 26, 2018.
Strength
40 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382025110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206536On Market Since
11/21/2018
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 392 times since Dec 26, 2018, and over the history we have for it it has declined 63.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0379 per EA |
|---|---|
| All-time high | $0.1103 (Jun 12, 2019) |
| All-time low | $0.0379 (Jun 17, 2026) |
| 52-week high | $0.0463 |
| 52-week low | $0.0379 |
| Median price | $0.0610 |
| Average price | $0.0653 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 392 |
| Tracking since | Dec 26, 2018 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0379 per EA (NDC 68382025110), effective Jun 24, 2026.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 63.2%. It has been tracked across 392 weekly CMS publications since Dec 26, 2018.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Dec 26, 2018, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0379 (Jun 17, 2026) to a high of $0.1103 (Jun 12, 2019), with a median of $0.0610 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ATORVASTATIN 40 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 68382025110) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification